DDC-2

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

一种Cu(DDC)2纳米核脂质体及其制备方法和应用
Applicant: 沈阳药科大学Priority: 2019
CN
Gene therapy DNA vector based on gene therapy DNA vector GDTT1.8NAS12 carrying the therapeutic gene selected from the group of DDC, IL10, IL13, IFNB1, TNFRSF4, TNFSF10, BCL2, HGF, and IL-2 genes for increasing the expression level of these therapeutic genes, method of its production and use, Escherichia coli strain JM110-NAS/GDTT1.8NAS12-DDC, or Escherichia coli strain JM110-NAS/GDTT1.8NAS12-IL10, or Escherichia coli strain JM110-NAS/GDTT1.8NAS12-IL13, or Escherichia coli strain JM110-NAS/GDTT1.
Applicant: GENETIC DIAGNOSTICS AND THERAPY 21 LTDPriority: 2020
US
Method and composition to individualize Levodopa/Carbidopa therapy using a breath test
Applicant: MODAK ANIL SPriority: 2005
US
WO
2 publications
Melatonin synthetase derived from intestinal bacteria and application of melatonin synthetase
Applicant: SHENZHEN INST OF ADVANCED TECHNOLOGY CHINESE ACADEMY OF SCIENCESPriority: 2025
CN
Application of schisantherin A in preparation of medicine for treating cholestatic liver disease
Applicant: SHUGUANG HOSPITAL AFFILIATED WITH SHANGHAI UNIV TCMPriority: 2022
CN
Anti-cancer transdermic absorption preparation
Applicant: NUOMA (BEIJING) TECH CO LTDPriority: 2016
CN
双硫仑联合铜补充剂在制备抗RNA病毒的药物中的应用
Applicant: 上海科技大学Priority: 2021
CN
3-ene-8-ethyl-2,7,12,15,18-pentamethyl-13-carboxylic acid-17-propionic acid amino acid amide, its synthetic method and light power therapeutic medicine
Applicant: GEN HOSPITAL PLAPriority: 2006
CN